Diagnostic Accuracy of MRI for Detecting the Preoperative Tumor Staging of Colorectal Carcinoma : MRI for the Preoperative Tumor Staging of Colorectal Carcinoma

Amir  Iqbal Memon; Samina  Naz; Urham  Jalees; Aisha  Masroor Bhatti; Ramsha  Khan; Maria  Zeb

doi:10.54393/pjhs.v3i07.386

Authors

Amir Iqbal Memon Department of Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan https://orcid.org/0000-0002-4336-8150
Samina Naz Department of Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Urham Jalees Department of Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Aisha Masroor Bhatti Department of Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Ramsha Khan Department of Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Maria Zeb Department of Surgery, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v3i07.386

Keywords:

Colorectal cancer, MRI, Tumor Staging, Diagnosis

Abstract

Colorectal cancer is the third most common carcinoma worldwide and is second leading cause of death in the developed world. Early detection of tumor staging may lead to opting proper management plan and increase chances of survival. Objective: To determine diagnostic accuracy of MRI in evaluating preoperative tumor staging of colorectal carcinoma. Methods: The cross-sectional study was conducted at, Liaquat University Hospital - Hyderabad/Jamshoro from Jan 2022 to July 2022 on a sample of 204 patients of either gender with aged between 20 to 80 years and presenting with suspected colorectal cancer, diagnosed on the basis of clinical symptoms and physical examination. Patients were enquired about age, gender, duration of symptoms, history of per-rectal bleeding and pain. Preoperative MRI scan along with the Postoperative histopathological assessment of colorectal carcinoma staging of all patients was done. Results: Out of 204 patients, 60% of sample i.e. 123 patients were male and 81 (40%) were females with a median age of 68 (29-92) years. Most of the patients had well differentiated colorectal cancers i.e. 175 (85.8%) with 2/3^rd sample had more than 5 cm height of primary tumor from the anal verge. T3 tumor stage was found to be highest in number (50.5%), followed by T2 (30.9%) and T4 (11.3%). The diagnostic parameters of preoperative MRI in detecting tumor staging was found to be good when correspondent to postoperative histological findings. Conclusion: The study showed that the accuracy of MRI in staging colorectal cancer is significantly high when compared with postoperative histopathological staging.

References

White PM, Sahu M, Poles MA, Francois F. Colorectal cancer screening of high-risk populations: A national survey of physicians. BMC Res Notes. 2012 Jan 24; 5(1): 1-6. doi: 10.1186/1756-0500-5-64

Siegel RL, Ward EM, Jemal A. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiology and Biomarkers Prevelence. 2012 Mar; 21(3): 411-6. doi: 10.1158/1055-9965.EPI-11-1020

Ghieda U, Hassanen O, Eltomey MA. MRI of rectal carcinoma: Preoperative staging and planning of sphincter-sparing surgery. The Egyptian Journal of Radiology and Nuclear Medicine. 2014 Mar; 45(1): 1-5. doi: 10.1016/j.ejrnm.2013.11.004

Zhang XM, Zhang HL, Yu D, Dai Y, Bi D, Prince MR, Li C. 3-T MRI of rectal carcinoma: preoperative diagnosis, staging, and planning of sphincter-sparing surgery. American Journal of Roentgenology. 2008 May; 190(5): 1271-8. doi: 10.2214/AJR.07.2505

Giusti S, Buccianti P, Castagna M, Fruzzetti E, Fattori S, Castelluccio E, et al. Preoperative rectal cancer staging with phased-array MR. Radiation oncology. 2012 Dec; 7(1): 1-10. doi: 10.1186/1748-717X-7-29

Uçar A, Obuz F, Sökmen S, Terzi C, Sağol Ö, Sarıoğlu S, et al. Efficacy of high resolution magnetic resonance imaging in preoperative local staging of rectal cancer. Molecular imaging and radionuclide therapy. 2013 Aug; 22(2): 42-48. doi: 10.4274/Mirt.43153

Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Annals of Surgical Oncology. 2012 Jul; 19(7): 2212-23. doi: 10.1245/s10434-011-2210-5

Nougaret S, Rouanet P, Molinari N, Pierredon MA, Bibeau F, Azria D, et al. MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy. Radiology. 2012 May; 263(2): 409-18. doi: 10.1148/radiol.12111263

Beets-Tan RG, Lambregts DM, Maas M, Bipat S, Barbaro B, Caseiro-Alves F, Curvo-Semedo L, et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European radiology. 2013 Sep; 23(9): 2522-31. doi: 10.1007/s00330-013-2864-4

Alberda WJ, Dassen HP, Dwarkasing RS, Willemssen FE, van der Pool AE, de Wilt JH, et al. Prediction of tumor stage and lymph node involvement with dynamic contrast-enhanced MRI after chemoradiotherapy for locally advanced rectal cancer. International Journal of Colorectal Disease. 2013 Apr 1; 28(4): 573-80. doi: 10.1007/s00384-012-1576-6

Heijnen LA, Lambregts DM, Martens MH, Maas M, Bakers FC, Cappendijk VC, et al. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?. European radiology. 2014 Feb; 24(2): 371-9. doi: 10.1007/s00330-013-3016-6

Rudisch A, Kremser C, Judmaier W, Zunterer H, DeVries AF. Dynamic contrast-enhanced magnetic resonance imaging: a non-invasive method to evaluate significant differences between malignant and normal tissue. European journal of radiology. 2005 Mar; 53(3): 514-9. doi: 10.1016/j.ejrad.2004.06.002

Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rödel CD, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 2017 Jul; 28: iv22-40. doi: 10.1093/annonc/mdx224

Jhaveri KS and Hosseini-Nik H. MRI of rectal cancer: an overview and update on recent advances. American Journal of Roentgenology. 2015 Jul; 205(1): W42-55. doi: 10.2214/AJR.14.14201

Gross CP, McAvay GJ, Krumholz HM, Paltiel AD, Bhasin D, Tinetti ME. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Annals of internal medicine. 2006 Nov; 145(9): 646-53. doi: 10.7326/0003-4819-145-9-200611070-00006

Cheung WY, Renfro LA, Kerr D, De Gramont A, Saltz LB, Grothey A, et al. Determinants of early mortality among 37,568 patients with colon cancer who participated in 25 clinical trials from the adjuvant colon cancer endpoints database. Journal of Clinical Oncology. 2016 Apr; 34(11): 1182. doi: 10.1200/JCO.2015.65.1158

Dieguez A. Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging. Cancer Imaging. 2013; 13(2): 277. doi: 10.1102/1470-7330.2013.0028

Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, et al. Colorectal cancer statistics, 2017. CA: a cancer journal for clinicians. 2017 May; 67(3): 177-93. doi: 10.3322/caac.21395

Battersby NJ, Moran B, Yu S, Tekkis P, Brown G. MR imaging for rectal cancer: the role in staging the primary and response to neoadjuvant therapy. Expert review of gastroenterology & hepatology. 2014 Aug; 8(6): 703-19. doi: 10.1586/17474124.2014.906898

Gaertner WB, Kwaan MR, Madoff RD, Melton GB. Rectal cancer: An evidence-based update for primary care providers. World Journal of Gastroenterology: WJG. 2015 Jul; 21(25): 7659.doi: 10.3748/wjg.v21.i25.7659

Vignali A, De Nardi P. Multidisciplinary treatment of rectal cancer in 2014: where are we going? World Journal of Gastroenterology. 2014 Aug; 20(32): 11249-61.doi: 10.3748/wjg.v20.i32.11249

Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Journal of British Surgery. 2003 Mar; 90(3): 355-64. doi: 10.1002/bjs.4034

Burton S, Brown G, Daniels IR, Norman AR, Mason B, Cunningham D. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins?. British journal of cancer. 2006 Feb; 94(3): 351-7. doi: 10.1038/sj.bjc.6602947

Moreno CC, Sullivan PS, Kalb BT, Tipton RG, Hanley KZ, Kitajima HD, et al. Magnetic resonance imaging of rectal cancer: staging and restaging evaluation. Abdominal imaging. 2015 Oct; 40(7): 2613-29. doi: 10.1007/s00261-015-0394-z

MacDermid E, Hooton G, MacDonald M, McKay G, Grose D, Mohammed N, et al. Improving patient survival with the colorectal cancer multi‐disciplinary team. Colorectal Disease. 2009 Mar; 11(3): 291-5. doi: 10.1111/j.1463-1318.2008.01580.x

Swellengrebel HA, Peters EG, Cats A, Visser O, Blaauwgeers HG, Verwaal VJ, et al. Multidisciplinary discussion and management of rectal cancer: a population-based study. World journal of surgery. 2011 Sep; 35(9): 2125-33. doi: 10.1007/s00268-011-1181-9

White A, Ironmonger L, Steele RJ, Ormiston-Smith N, Crawford C, Seims A. A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK. BMC cancer. 2018 Dec;18(1):1-1. doi: 10.1186/s12885-018-4786-7

Georgiou PA, Tekkis PP, Constantinides VA, Patel U, Goldin RD, Darzi AW, et al. Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. European Journal of Cancer. 2013 Jan;49(1):72-81. doi: 10.1016/j.ejca.2012.06.025

Taylor FG, Swift RI, Blomqvist L, Brown G. A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. American Journal of Roentgenology. 2008 Dec;191(6):1827-35.